Cited by

• Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.

  McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE. McCurry KR, et al. J Thorac Cardiovasc Surg. 2005 Aug;130(2):528-37. doi: 10.1016/j.jtcvs.2004.09.040. J Thorac Cardiovasc Surg. 2005. PMID: 16077423 Free PMC article.
• Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.

  Thai NL, Khan A, Tom K, Blisard D, Basu A, Tan HP, Marcos A, Fung JJ, Starzl TE, Shapiro R. Thai NL, et al. Transplantation. 2006 Dec 27;82(12):1621-4. doi: 10.1097/01.tp.0000250712.12389.3d. Transplantation. 2006. PMID: 17198247 Free PMC article.
• Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.

  Varco-Merth B, Chaunzwa M, Duell DM, Marenco A, Goodwin W, Dannay R, Nekorchuk M, Shao D, Busman-Sahay K, Fennessey CM, Silipino L, Hull M, Bosche WJ, Fast R, Oswald K, Shoemaker R, Bochart R, MacAllister R, Labriola CS, Smedley JV, Axthelm MK, Davenport MP, Edlefsen PT, Estes JD, Keele BF, Lifson JD, Lewin SR, Picker LJ, Okoye AA. Varco-Merth B, et al. PLoS Pathog. 2024 Aug 22;20(8):e1012496. doi: 10.1371/journal.ppat.1012496. eCollection 2024 Aug. PLoS Pathog. 2024. PMID: 39173097 Free PMC article.
• Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.

  Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, Murase N, Zeevi A, Girnita A, Metes D, Ness R, Bass DC, Demetris AJ, Fung JJ, Marcos A, Starzl TE. Shapiro R, et al. J Am Coll Surg. 2005 Apr;200(4):505-15; quiz A59-61. doi: 10.1016/j.jamcollsurg.2004.12.024. J Am Coll Surg. 2005. PMID: 15804464 Free PMC article.
• Immunosuppressive preconditioning or induction regimens : evidence to date.

  Tan HP, Smaldone MC, Shapiro R. Tan HP, et al. Drugs. 2006;66(12):1535-45. doi: 10.2165/00003495-200666120-00001. Drugs. 2006. PMID: 16956302 Review.